• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CVRX, INC. BAROSTIM NEO; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CVRX, INC. BAROSTIM NEO; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number 2102
Device Problem Unintended Movement (3026)
Patient Problem Implant Pain (4561)
Event Date 06/21/2018
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Cvrx id# (b)(4).
 
Event Description
A barostim system was implanted on (b)(6), 2018.The patient reported experiencing discomfort and pain at both the ipg and csl locations and intermittent swelling at the csl electrode location since implant, but the symptoms had worsened.An x-ray was performed and no signs of infection were observed.However, the x-ray also showed the ipg looked to have migrated and was currently positioned at the level of the breast.It was unknown if the ipg was sutured with two sutures during the implant procedure.The surgeon planned to implant a new ipg on the opposite side.However, the patient developed covid, and the procedure was postponed.The patient was unresponsive to the clinic's attempts to bring them back which, in the opinion of the site, was related to the patient not wanting to be tested for medical compliance.A procedure occurred on (b)(6), 2023, and the system on the right side was explanted.It was found that the ipg had been sutured with two sutures, but the ipg had moved approximately 20 cm down from the initial pocket.It was observed that there were adhesions on the existing csl, and the csl was accidentally damaged when the surgeon tried to remove the adhesions.A lead repair was started, but the surgeon decided to cancel the repair and use a new csl.No lead repair parts remained in the patient.A new barostim system was implanted on the left side.A follow-up was scheduled for a few weeks.
 
Manufacturer Narrative
Cvrx id#: (b)(4).
 
Event Description
A barostim system was implanted on (b)(6) 2018.The patient reported experiencing discomfort and pain at both the ipg and csl locations and intermittent swelling at the csl electrode location since implant, but the symptoms had worsened.An x-ray was performed and no signs of infection were observed.However, the x-ray also showed the ipg looked to have migrated and was currently positioned at the level of the breast.It was unknown if the ipg was sutured with two sutures during the implant procedure.The surgeon planned to implant a new ipg on the opposite side.However, the patient developed covid, and the procedure was postponed.The patient was unresponsive to the clinic's attempts to bring them back which, in the opinion of the site, was related to the patient not wanting to be tested for medical compliance.A procedure occurred on (b)(6) 2023, and the system on the right side was explanted.It was found that the ipg had been sutured with two sutures, but the ipg had moved approximately 20 cm down from the initial pocket.It was observed that there were adhesions on the existing csl, and the csl was accidentally damaged when the surgeon tried to remove the adhesions.A lead repair was started, but the surgeon decided to cancel the repair and use a new csl.No lead repair parts remained in the patient.A new barostim system was implanted on the left side.As of on (b)(6) 2023, the patient was feeling well with no additional reported events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAROSTIM NEO
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer (Section G)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer Contact
sarah hicks
9201 west broadway avenue
suite 650
minneapolis, MN 55445
MDR Report Key17370373
MDR Text Key319485731
Report Number3007972010-2023-00033
Device Sequence Number1
Product Code DSR
UDI-Device Identifier00859144004005
UDI-Public(01)00859144004005(17)200117
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P180050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/17/2020
Device Model Number2102
Device Catalogue Number100054-201
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/17/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
Patient SexFemale
Patient Weight90 KG
Patient EthnicityNon Hispanic
-
-